ZURZUVAE Capsules 30mg Drug Use-results Survey

ZURZUVAE Capsules 30mg Drug Use-results Survey - ZURZUVAE Capsules 30mg Drug Use-results Survey

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000060985

Enrollment

1500

Registered

2026-03-19

Start date

2026-04-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression or Depressed State

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient with depression or depressed state who has not been treated with ZURZUVAE Capsules and provides an informed consent in written for data collection and analysis

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
Safety Incidence of adverse drug reactions	—

Countries

Japan

Contacts

Public ContactYumina Oiwa

Shionogi & Co., Ltd. Pharmacovigilance Department

yumina.oiwa@shionogi.co.jp+81-6-6202-2161

Outcome results